Breaking News

Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for the Treatment of Relapsed or Refractory Multiple Myeloma Siemens and NVIDIA to Enable Industrial Metaverse Boeing Releases 2022 Sustainability Report, Maps Sustainable Aerospace Progress Models predict that planned phosphorus reductions will make Lake Erie more toxic | Beta site for NSF Lam Research Outlines Path, Progress to Net Zero Emissions Readout of Secretary of Defense Lloyd Austin’s Call With Ukraine’s Minister of Defence Oleksii Reznikov > U.S. Department of Defense > Release Remarks by U.S. Secretary of Commerce Gina Raimondo at the Bureau of Industry and Security (BIS) Update Conference Gov. Wolf Announces GLG Expanding Into Pennsylvania, Creating 250 Good-Paying Jobs in Philadelphia 

FOR IMMEDIATE RELEASE

CONTACT: Wes Stubblefield, M.D., (256) 340-2113

The U.S. Food and Drug Administration (FDA) has issued a Public Health Advisory for powdered formulations of Similac®, Alimentum®, and EleCare® formulas manufactured by Abbott Nutrition in its Sturgis, Michigan, facility. The Alabama WIC Program is notifying participants that they may have been issued affected product.

Abbott Nutrition is voluntarily recalling these products after four consumer complaints related to to Cronobacter sakazakii or Salmonella Newport in infants who had consumed powder infant formula manufactured in this facility. No distributed product has tested positive for the presence of either of these bacteria; however, routine testing is ongoing. As a proactive measure, the FDA is advising consumers not to use Similac®, Alimentum® and EleCare® powdered formulas if:

  • the first two digits of the code are 22 through 37 and
  • the code on the container contains K8, SH, pr Z2, and
  • the expiration date is 4-1-2022 (APR 2022) or later

Products that do not contain the information listed above are not impacted by the advisory issued by the FDA on February 17. This advisory is for powder formulas only and does not contain other physical formulations such as liquid concentrate or ready-to-feed. This recall does not include any metabolic deficiency nutrition formulas. Persons who have questions or need assistance in locating the product code, are asked to contact Abbott Nutrition Consumer Relations at 1-800-986-8540.

WIC participants should return any of the affected formula to the store or WIC clinic where the products were obtained. When returning the products to retailers, WIC participants must show their eWIC card to customer service to process the exchange. At this time, available inventory may be limited. If a participant is unable to complete an exchange, WIC will arrange a reasonable substitute in coordination with the participant’s medical provider. Non-WIC purchases by the general public may be returned according to Abbott’s recall website instructions.

Signs and symptoms of illness related to these bacteria and more information are available on FDA’s website and Abbott’s Similac Recall website listed below:

A photograph of the potentially affected product codes and where the code is printed on the product packaging may be viewed at alabamapublichealth.gov. WIC participants also may contact their local county health department, the State WIC Office at 334-206-5673, or 1-888-942-4673, for questions regarding potentially affected formula products being recalled.

-30-

2/18/22


County health departments throughout Alabama provide a wide range of confidential and professional services. Contact your local county health department for additional information.

Mission: To promote, protect, and improve Alabama’s health

Vision: Healthy People. Healthy Communities. Healthy Alabama.

Source link